InvestorsHub Logo
Followers 9
Posts 740
Boards Moderated 0
Alias Born 01/15/2014

Re: None

Saturday, 02/03/2018 2:19:44 AM

Saturday, February 03, 2018 2:19:44 AM

Post# of 18422
Hello??Hello????
Recent Support of Countermeasure Development Poised to Continue in Reauthorization of PAHPA
January 29, 2018

"Targeted threats included influenza, Ebola, Zika, Marburg, anthrax, plague, glanders, tularemia, and Middle East Respiratory Syndrome Coronavirus or “MERS-CoV.”

"..the upcoming reauthorization of the Pandemic and All-Hazards Preparedness Act (“PAHPA”), and its prior reauthorization, may present a critical opportunity to continue to improve public-private relationships in countermeasure development.

"Since the passage of the 21st Century Cures Act, various components of the U.S. Government have continued to support countermeasure development.

"As detailed in a recent report, the U.S. Government made a wide range of investments for countermeasures and diagnostic throughout 2017 in the form of funding, expertise, and other resources.

"Targeted threats included influenza, Ebola, Zika, Marburg, anthrax, plague, glanders, tularemia, and Middle East Respiratory Syndrome Coronavirus or “MERS-CoV.”

" the program incentivizes development by providing vouchers to sponsors of new approved countermeasures that target specific threats.

"The vouchers can be used to expedite the FDA’s review of other products, which in turn can result in early market entry and effectively extend the productive life of associated patent rights.

"September 30 deadline for reauthorizing PAHPA." 8 months away
https://www.insidegovernmentcontracts.com/2018/01/recent-support-of-countermeasure-development-poised-to-continue-in-reauthorization-of-pahpa/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News